EA201690966A1 - Новое соединение для лечения тяжелой гипогликемии - Google Patents
Новое соединение для лечения тяжелой гипогликемииInfo
- Publication number
- EA201690966A1 EA201690966A1 EA201690966A EA201690966A EA201690966A1 EA 201690966 A1 EA201690966 A1 EA 201690966A1 EA 201690966 A EA201690966 A EA 201690966A EA 201690966 A EA201690966 A EA 201690966A EA 201690966 A1 EA201690966 A1 EA 201690966A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lys
- ser
- treatment
- hypoglycemia
- thr
- Prior art date
Links
- 208000013016 Hypoglycemia Diseases 0.000 title abstract 2
- 230000002218 hypoglycaemic effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
В настоящем изобретении предложено новое соединение, содержащее аминокислотную последовательность Tyr-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-(Aib)-Lys-Lys-Ala-Gln-Glu-Phe-Val-Glu-Trp-Leu-Leu-Lys-Thr-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Lys-Ser-Lys-NH2 (SEQ ID NO: 2), применяемое для лечения гипогликемии. Изобретение также относится к фармацевтическим композициям, содержащим указанное соединение, соответствующим способам лечения и применению.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361917716P | 2013-12-18 | 2013-12-18 | |
| PCT/US2014/069644 WO2015094876A1 (en) | 2013-12-18 | 2014-12-11 | Novel compound for treatment of severe hypoglycemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201690966A1 true EA201690966A1 (ru) | 2016-12-30 |
Family
ID=52273565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201690966A EA201690966A1 (ru) | 2013-12-18 | 2014-12-11 | Новое соединение для лечения тяжелой гипогликемии |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20160311882A1 (ru) |
| EP (1) | EP3083667A1 (ru) |
| KR (1) | KR20160075826A (ru) |
| CN (1) | CN105829340A (ru) |
| AP (1) | AP2016009267A0 (ru) |
| AR (1) | AR098615A1 (ru) |
| AU (1) | AU2014366425B2 (ru) |
| BR (1) | BR112016010635A2 (ru) |
| CA (1) | CA2930596A1 (ru) |
| CR (1) | CR20160227A (ru) |
| DO (1) | DOP2016000142A (ru) |
| EA (1) | EA201690966A1 (ru) |
| HK (1) | HK1224305A1 (ru) |
| IL (1) | IL245491A0 (ru) |
| MA (1) | MA39110B1 (ru) |
| MX (1) | MX2016007988A (ru) |
| PE (1) | PE20160847A1 (ru) |
| PH (1) | PH12016501183A1 (ru) |
| SG (1) | SG11201604237PA (ru) |
| TN (1) | TN2016000208A1 (ru) |
| TW (1) | TW201609128A (ru) |
| WO (1) | WO2015094876A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI622596B (zh) | 2015-10-26 | 2018-05-01 | 美國禮來大藥廠 | 升糖素受體促效劑 |
| WO2019140024A1 (en) | 2018-01-12 | 2019-07-18 | Eli Lilly And Company | Combination therapy |
| CA3128922A1 (en) | 2019-02-05 | 2020-08-13 | Eli Lilly And Company | Glucagon analog agonists and methods of using the same |
| CN113677702B (zh) | 2019-04-01 | 2025-06-13 | 诺和诺德股份有限公司 | 针对利拉鲁肽的抗体及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2674354A1 (en) | 2007-01-05 | 2008-07-17 | Indiana University Research And Technology Corporation | Glucagon analogs exhibiting enhanced solubility in physiological ph buffers |
| EP2249853A4 (en) * | 2008-01-30 | 2012-12-26 | Univ Indiana Res & Tech Corp | ESTER BASED PEPTIDE PRODRUGS |
| CA2727161A1 (en) * | 2008-06-17 | 2009-12-23 | Indiana University Research And Technology Corporation | Glucagon analogs exhibiting enhanced solubility and stability physiological ph buffers |
| EP2512503A4 (en) * | 2009-12-18 | 2013-08-21 | Univ Indiana Res & Tech Corp | COAGONISTS OF GLUCAGON / GLP-1 RECEPTOR |
| BR112013031794B1 (pt) * | 2011-06-10 | 2020-11-10 | Hanmi Science Co., Ltd | peptídeo derivados de oxintomodulina e seu uso, polinucleotídeo, composição farmacêutica e seu uso e método para prevenção ou tratamento da obesidade compreendendo os mesmos |
| US9944687B2 (en) * | 2011-07-04 | 2018-04-17 | Imperial Innovations Limited | Compounds and their effects on feeding behaviour |
-
2014
- 2014-12-04 AR ARP140104513A patent/AR098615A1/es unknown
- 2014-12-05 TW TW103142473A patent/TW201609128A/zh unknown
- 2014-12-11 CN CN201480069406.3A patent/CN105829340A/zh active Pending
- 2014-12-11 MA MA39110A patent/MA39110B1/fr unknown
- 2014-12-11 KR KR1020167015880A patent/KR20160075826A/ko not_active Withdrawn
- 2014-12-11 TN TN2016000208A patent/TN2016000208A1/en unknown
- 2014-12-11 MX MX2016007988A patent/MX2016007988A/es unknown
- 2014-12-11 HK HK16112378.9A patent/HK1224305A1/zh unknown
- 2014-12-11 BR BR112016010635A patent/BR112016010635A2/pt not_active IP Right Cessation
- 2014-12-11 AP AP2016009267A patent/AP2016009267A0/en unknown
- 2014-12-11 PE PE2016000771A patent/PE20160847A1/es not_active Application Discontinuation
- 2014-12-11 CA CA2930596A patent/CA2930596A1/en not_active Abandoned
- 2014-12-11 US US15/103,130 patent/US20160311882A1/en not_active Abandoned
- 2014-12-11 EP EP14821418.2A patent/EP3083667A1/en not_active Withdrawn
- 2014-12-11 WO PCT/US2014/069644 patent/WO2015094876A1/en active Application Filing
- 2014-12-11 EA EA201690966A patent/EA201690966A1/ru unknown
- 2014-12-11 SG SG11201604237PA patent/SG11201604237PA/en unknown
- 2014-12-11 AU AU2014366425A patent/AU2014366425B2/en not_active Ceased
-
2016
- 2016-05-05 IL IL245491A patent/IL245491A0/en unknown
- 2016-05-18 CR CR20160227A patent/CR20160227A/es unknown
- 2016-06-15 DO DO2016000142A patent/DOP2016000142A/es unknown
- 2016-06-17 PH PH12016501183A patent/PH12016501183A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CR20160227A (es) | 2016-07-12 |
| TW201609128A (zh) | 2016-03-16 |
| AU2014366425B2 (en) | 2016-12-08 |
| IL245491A0 (en) | 2016-06-30 |
| HK1224305A1 (zh) | 2017-08-18 |
| BR112016010635A2 (pt) | 2017-12-05 |
| MX2016007988A (es) | 2016-09-09 |
| TN2016000208A1 (en) | 2017-10-06 |
| US20160311882A1 (en) | 2016-10-27 |
| PH12016501183A1 (en) | 2016-07-25 |
| MA39110B1 (fr) | 2018-04-30 |
| CA2930596A1 (en) | 2015-06-25 |
| AP2016009267A0 (en) | 2016-06-30 |
| AR098615A1 (es) | 2016-06-01 |
| PE20160847A1 (es) | 2016-09-10 |
| WO2015094876A1 (en) | 2015-06-25 |
| DOP2016000142A (es) | 2016-07-15 |
| AU2014366425A1 (en) | 2016-05-26 |
| KR20160075826A (ko) | 2016-06-29 |
| CN105829340A (zh) | 2016-08-03 |
| SG11201604237PA (en) | 2016-07-28 |
| MA39110A1 (fr) | 2017-09-29 |
| EP3083667A1 (en) | 2016-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
| EA201790764A1 (ru) | Новые соединения карбоновых кислот, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1 | |
| EA201990071A1 (ru) | Композиция пептидной вакцины | |
| EA201990043A1 (ru) | Антибактериальные соединения | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| EA202090593A3 (ru) | Пептидное соединение | |
| EA201500923A1 (ru) | Замещенные (бензилцианометил)амиды 2-азабицикло[2.2.1]гептан-3-карбоновых кислот в качестве ингибиторов катепсина с | |
| EA201500802A1 (ru) | Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы | |
| EA201071169A1 (ru) | ГИДРОКСИМЕТИЛПИРРОЛИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ β3 | |
| EA201591745A1 (ru) | 3-пиримидин-4-ил-оксазолидин-2-оны в качестве ингибиторов мутантого idh | |
| EA202092187A1 (ru) | Способы лечения эпителиоидно-клеточных опухолей | |
| UA110612C2 (ru) | Производные 1-амино-2-циклопропилетилбороновои кислоты | |
| EA201790576A1 (ru) | Спироциклические ингибиторы катепсина с | |
| EP4414376A3 (en) | Novel depsipeptide and uses thereof | |
| MX2017009595A (es) | Compuestos antisenescentes y usos de los mismos. | |
| EA201490790A1 (ru) | Пептидные конъюгаты агониста рецептора гастрина и глюкагон подобного пептида 1 | |
| JO3092B1 (ar) | مركب لتحفيز مسيطر عليه للمبيض | |
| EA201692548A1 (ru) | Минеральные аминокислотные комплексы активных веществ | |
| EA202190588A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| EA201491500A1 (ru) | Способы лечения фиброза | |
| RU2015119523A (ru) | Новый способ лечения повреждения спинного мозга с применением фрагмента hmgb1 | |
| EA201790223A1 (ru) | Водный препарат, содержащий парацетамол и ибупрофен | |
| EA202191478A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата |